Topics

IJU this issue.

07:00 EST 1st December 2019 | BioPortfolio

Summary of "IJU this issue."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: International journal of urology : official journal of the Japanese Urological Association
ISSN: 1442-2042
Pages: 1089

Links

DeepDyve research library

Clinical Trials [666 Associated Clinical Trials listed on BioPortfolio]

Effect of Pregabalin on Propofol Induction Dose

The primary issue is to determine whether preoperatively administered pregabalin decreases the necessary dose of propofol during induction of general anesthesia. The investigators secondar...

Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting

Several studies have shown the beneficial effect of zinc treatment in acute diarrhea. There was a significant reduction in duration of the treated episodes and in their severity as measure...

Statin Eligibility Prior to Myocardial InfarCtion

The study (Statin Eligibility Prior to myocardial infarction (MI) in Jordanians, StatinEPIC) is 1. Cross sectional 2. Non interventional 3. One encounter per patient. ...

PK/PD of Vitamin D3 in Adults With CF

Despite the extensive literature on adverse clinical outcomes associated with vitamin D deficiency, there are currently no proven treatment strategy that effectively achieves and maintains...

Nutrition and Chemotherapy

Patients treated for cancer nowadays have many means of information and tend to become more and more involved in their health. The interest of a therapeutic fast with detoxifying or even c...

Medical and Biotech [MESH] Definitions

Active involvement in the political process including promoting, impeding or raising awareness of a certain issue or set of issues.

Prefactory summary to a special issue or section of a journal devoted to a specific topic. This introductory text can be of varying length and substance.

The removal of a consumer product from the market place. The reason for the removal can be due a variety of causes, including the discovery of a manufacturing defect, a safety issue with the product's use, or marketing decisions.

Withholding or withdrawal of a particular treatment or treatments, often (but not necessarily) life-prolonging treatment, from a patient or from a research subject as part of a research protocol. The concept is differentiated from REFUSAL TO TREAT, where the emphasis is on the health professional's or health facility's refusal to treat a patient or group of patients when the patient or the patient's representative requests treatment. Withholding of life-prolonging treatment is usually indexed only with EUTHANASIA, PASSIVE, unless the distinction between withholding and withdrawing treatment, or the issue of withholding palliative rather than curative treatment, is discussed.

Quick Search


DeepDyve research library

Searches Linking to this Article